![Zhen Yu Xiao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhen Yu Xiao
Directeur Général chez
Hermed Equity Investment Management Shanghai Co. Ltd.
Profil
Zhen Yu Xiao is currently the Chief Executive Officer at Hermed Equity Investment Management Shanghai Co. Ltd. and a Director at Aadi Subsidiary, Inc. He previously served as an Independent Director at DiaMedica Therapeutics, Inc., a Director at Applied StemCell, Inc., and a Managing Director at Hermed Capital Co. Ltd. From 2008 to 2014, he was an Associate General Manager at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Postes actifs de Zhen Yu Xiao
| Sociétés | Poste | Début |
|---|---|---|
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Directeur/Membre du Conseil | - |
Hermed Equity Investment Management Shanghai Co. Ltd. | Directeur Général | - |
Hermed Capital Co. Ltd.
 Hermed Capital Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | - |
Anciens postes connus de Zhen Yu Xiao
| Sociétés | Poste | Fin |
|---|---|---|
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Corporate Officer/Principal | 01/11/2014 |
Applied StemCell, Inc.
 Applied StemCell, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in cell and gene therapy development research | Directeur/Membre du Conseil | - |
| DIAMEDICA THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Applied StemCell, Inc.
Applied StemCell, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in cell and gene therapy development research | Health Technology |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines, pharmaceuticals and medical equipment | Health Technology |
Hermed Capital Co. Ltd.
Hermed Capital Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Hermed Equity Investment Management Shanghai Co. Ltd. |
